Pathologically confirmed malignant tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Treatment-naïve patients with histologically verified primary malignancy; 2.Time since diagnosis= 6 months; 3.Age>=18 and <=75 years with ability to complete questionnaires independently; 4.With elementary school or higher education, normal communication capacity, and good compliance;
Exclusion criteria
Exclusion criteria: 1.Organic brain disorders • Cerebral metastatic disease • Any condition impairing insight; 2.Individuals requesting medical confidentiality; 3.Patients currently taking anxiolytics, hypnotics, or other psychotropic medications that may affect mental status, as well as those requiring pharmacological intervention for excessive anxiety or insomnia during the study period; 4.Patients currently participating in similar clinical studies;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PQSI;SDS;SAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence to treatment;Patient satisfaction; | — |
Countries
China
Contacts
Fifth Affiliated Hospital, Sun Yat-Sen University